Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma
Publication type: Journal Article
Publication date: 2010-08-03
scimago Q1
wos Q1
SJR: 0.870
CiteScore: 8.9
Impact factor: 3.9
ISSN: 1061186X, 10292330, 10267158
PubMed ID:
20678009
Pharmaceutical Science
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Biochimie
3 publications, 11.11%
|
|
|
Pharmacological Research
2 publications, 7.41%
|
|
|
ACS Omega
2 publications, 7.41%
|
|
|
Journal of Drug Targeting
2 publications, 7.41%
|
|
|
Biology
1 publication, 3.7%
|
|
|
Pharmaceutics
1 publication, 3.7%
|
|
|
International Journal of Molecular Sciences
1 publication, 3.7%
|
|
|
Scientific Reports
1 publication, 3.7%
|
|
|
Cancer Letters
1 publication, 3.7%
|
|
|
Bioorganic and Medicinal Chemistry
1 publication, 3.7%
|
|
|
International Journal of Biological Macromolecules
1 publication, 3.7%
|
|
|
Acta Cirurgica Brasileira
1 publication, 3.7%
|
|
|
Journal of Experimental Botany
1 publication, 3.7%
|
|
|
FEMS Microbiology Letters
1 publication, 3.7%
|
|
|
Proceedings of the National Academy of Sciences of the United States of America
1 publication, 3.7%
|
|
|
Biochemistry (Moscow)
1 publication, 3.7%
|
|
|
Russian Journal of Oncology
1 publication, 3.7%
|
|
|
Pharmacological Research - Modern Chinese Medicine
1 publication, 3.7%
|
|
|
Биохимия
1 publication, 3.7%
|
|
|
Mendeleev Communications
1 publication, 3.7%
|
|
|
1
2
3
|
Publishers
|
2
4
6
8
10
|
|
|
Elsevier
10 publications, 37.04%
|
|
|
MDPI
3 publications, 11.11%
|
|
|
Springer Nature
2 publications, 7.41%
|
|
|
American Chemical Society (ACS)
2 publications, 7.41%
|
|
|
Taylor & Francis
2 publications, 7.41%
|
|
|
Oxford University Press
2 publications, 7.41%
|
|
|
Pleiades Publishing
2 publications, 7.41%
|
|
|
SciELO
1 publication, 3.7%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 3.7%
|
|
|
Eco-Vector LLC
1 publication, 3.7%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 3.7%
|
|
|
2
4
6
8
10
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
27
Total citations:
27
Citations from 2025:
3
(11.11%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Appel E. et al. Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma // Journal of Drug Targeting. 2010. Vol. 19. No. 5. pp. 326-335.
GOST all authors (up to 50)
Copy
Appel E., Rabinkov A., Neeman M., Kohen F., MIRELMAN D. Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma // Journal of Drug Targeting. 2010. Vol. 19. No. 5. pp. 326-335.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3109/1061186x.2010.504265
UR - https://doi.org/10.3109/1061186x.2010.504265
TI - Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma
T2 - Journal of Drug Targeting
AU - Appel, Elena
AU - Rabinkov, Aharon
AU - Neeman, Michal
AU - Kohen, Fortüne
AU - MIRELMAN, DAVID
PY - 2010
DA - 2010/08/03
PB - Taylor & Francis
SP - 326-335
IS - 5
VL - 19
PMID - 20678009
SN - 1061-186X
SN - 1029-2330
SN - 1026-7158
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2010_Appel,
author = {Elena Appel and Aharon Rabinkov and Michal Neeman and Fortüne Kohen and DAVID MIRELMAN},
title = {Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma},
journal = {Journal of Drug Targeting},
year = {2010},
volume = {19},
publisher = {Taylor & Francis},
month = {aug},
url = {https://doi.org/10.3109/1061186x.2010.504265},
number = {5},
pages = {326--335},
doi = {10.3109/1061186x.2010.504265}
}
Cite this
MLA
Copy
Appel, Elena, et al. “Conjugates of daidzein-alliinase as a targeted pro-drug enzyme system against ovarian carcinoma.” Journal of Drug Targeting, vol. 19, no. 5, Aug. 2010, pp. 326-335. https://doi.org/10.3109/1061186x.2010.504265.